Ellis Andras, MD
Radiation Oncologist
Asbestosis Diffuse Pleural Thickening Laryngeal Cancer Lung Cancer Ovarian Cancer Pericardial Mesothelioma Peritoneal Mesothelioma Pleural Effusions Pleural Mesothelioma Pleural Plaques Pleuritis Rounded Atelectasis Testicular Mesothelioma
Dr. Ellis Andras is a radiation oncologist based in Sacramento, California. He has an extensive medical experience of 46 years. Dr. Andras graduated in 1970 from the Louisiana State University in New Orleans. He did an internship at the Memorial Hermann Healthcare System followed by a residency at the same medical institution and another residency at the University of Texas MD Anderson Cancer Center. Dr. Andras is a board-certified specialist in Radiation Oncology. He is also an active researcher who contributed to several publications. Some of the topics he discussed include the benefits of treatment intensification in patients with non-small cell lung cancer, interfraction interval effects in patients with non-small cell lung cancer, concurrent chemotherapy addition to hyperfractionated radiotherapy. Dr. Andras is currently affiliated with multiple hospitals including the Mercy General Hospital, Sutter Medical Center Sacramento, and Sutter Davis Hospital.
Louisiana State University in New Orleans
Medical School
Memorial Hermann Healthcare System
Internship
Memorial Hermann Healthcare System
Residency
University of Texas MD Anderson Cancer Center
Residency
American Board of Radiology - Radiation Oncology
CA State Medical License
Sutter Medical Center Sacramento
Languages: English/Spanish
(916) 887-1130
2825 Capitol Ave
Read MoreSutter Roseville Medical Center
Languages: English/Spanish
(916) 781-1000
1 Medical Plaza Dr
Read MoreThe benefit of treatment intensification is age and histology-dependent in patients with locally advanced non-small cell lung cancer (NSCLC): a quality-adjusted surviv...
Movsas, B., Scott, C., Sause, W., Byhardt, R., Komaki, R., Cox, J., Johnson, D., Lawton, C., Dar, A. R., Wasserman, T., Roach, M., Lee, J. S., Andras, E.; Int J Radiat Oncol Biol Phys. 1999 Dec 1.
See more >>Interfraction interval does not affect survival of patients with non-small cell lung cancer treated with chemotherapy and/or hyperfractionated radiotherapy: a multivar...
Werner-Wasik, M., Scott, C., Graham, M. L., Smith, C., Byhardt, R. W., Roach, M., Andras, E. J.; Int J Radiat Oncol Biol Phys. 1999 May 1.
See more >>Impact of adding concurrent chemotherapy to hyperfractionated radiotherapy for locally advanced non-small cell lung cancer (NSCLC): comparison of RTOG 83-11 and RTOG 9...
Komaki, R., Scott, C., Lee, J. S., Urtasun, R. C., Byhardt, R. W., Emami, B., Andras, E. J., Asbell, S. O., Rotman, M., Cox, J. D.; Am J Clin Oncol. 1997 Oct.
See more >>